Navigation Links
Advanced Analytical Unveils New Instrument for Rapid Microbial Identification at BIO 2008
Date:5/20/2008

AMES, Iowa, May 20 /PRNewswire/ -- Advanced Analytical Technologies, Inc. (AATI), based in Ames, IA will unveil its newest instrument platform, the DNA PROfiler(TM) system, at BIO 2008. This instrument is being designed to significantly decrease the time to identify infections which could help clinicians treat patients sooner and with more knowledge.

Dr. Steven J Lasky, CEO of AATI, states, "We are excited about this new identification system. Very soon many diverse microbiology fields will be transformed by the ability to have molecular based microbial species identification in just 2 hours instead of 2 days. Up until now molecular-based identifications have been too costly, too labor intensive, and too slow."

Dr Gary Procop, Director, Molecular Microbiology, Mycology, and Parasitology of the Cleveland Clinic, states, "Soon doctors will no longer just ask yes or no questions about what might be causing an infection but will have unequivocal results. The beauty of this method is that a sequence-based, species-level identification could be available within hours of testing."

Unlike biochemical-based identification systems which can take days and rely on the viability and phenotypic characteristics of the microorganism, the DNA PROfiler(TM) system from AATI, will provide accurate and rapid species level identification of microorganisms. The system is nucleic acid based, coupling DNA amplification with capillary electrophoresis to provide sequence- based data. The DNA PROfiler(TM) system is under development. AATI is working with the Cleveland Clinic and other research institutes to evaluate the system and prepare it for commercial launch in 2009.

Providing rapid and accurate sequence-based data has applications in many fields besides microbial identification. These applications include plant and pharmaceutical sciences, consumer product testing as well as forensic testing. AATI is actively looking for strategic partners for these applications.

About Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) provides innovative solutions to improve processes and accelerate research within the pharmaceutical, life science, and personal care/OTC markets. AATI's portfolio includes technologies for the rapid detection and enumeration of microbes by flow cytometry, and the parallel analysis of pharmaceutical compounds or biomolecules by capillary electrophoresis with UV absorbance detection. For more information visit the company's website at http://www.aati-us.com or contact us at webinfo@aati-us.com

For information: http://www.aati-us.com

Contact: webinfo@aati-us.com

Phone: 515-296-6600

CONTACT

Jennifer Matthai

2711 S. Loop Dr.

Ames, IA 50010

Phone: 515-296-6600

http://www.aati-us.com

webinfo@aati-us.com


'/>"/>
SOURCE Advanced Analytical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a ... biotechnology industries to improve patient outcomes and quality of life, will now be ... are being attributed to new regulatory requirements for all new drug products, including ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions ... over 5.5 million people each year. Especially those living in larger cities are affected ... based in one of the most pollution-affected countries globally - decided to take action. ...
Breaking Biology Technology:
(Date:4/18/2017)... -- Socionext Inc., a global expert in SoC-based imaging and computing solutions, ... which features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ... will be showcased during the upcoming Medtec Japan at Tokyo Big ... Las Vegas Convention Center April 24-27. ... Click here for an image of ...
(Date:4/11/2017)... , Apr. 11, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global eye tracking market to grow at a CAGR ... Global Eye Tracking Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
Breaking Biology News(10 mins):